During the last session, Iovance Biotherapeutics Inc (NASDAQ:IOVA)’s traded shares were 21.4 million, with the beta value of the company hitting 1.07. At the end of the trading day, the stock’s price was $3.17, reflecting an intraday gain of 1.28% or $0.04. The 52-week high for the IOVA share is $13.88, that puts it down -337.85 from that peak though still a striking 14.83% gain since the share price plummeted to a 52-week low of $2.70. The company’s market capitalization is $1.06B, and the average trade volume was 10.07 million shares over the past three months.
Iovance Biotherapeutics Inc (IOVA) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.31. IOVA has a Sell rating from 0 analyst(s) out of 8 analysts who have looked at this stock. 2 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 6 recommend a Buy rating for it.
Iovance Biotherapeutics Inc (NASDAQ:IOVA) trade information
Iovance Biotherapeutics Inc (IOVA) registered a 1.28% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 1.28% in intraday trading to $3.17, hitting a weekly high. The stock’s 5-day price performance is -4.80%, and it has moved by 11.23% in 30 days. Based on these gigs, the overall price performance for the year is -77.16%.
The consensus price target of analysts on Wall Street is $6, which implies an increase of 47.17% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $6 and $6 respectively. As a result, IOVA is trading at a discount of -89.27% off the target high and -89.27% off the low.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 4.17%. While earnings are projected to return 35.47% in 2025.
IOVA Dividends
Iovance Biotherapeutics Inc is due to release its next quarterly earnings in June. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
The next largest institutional holding, with 25.93 million shares, is of PERCEPTIVE ADVISORS LLC’s that is approximately 9.1052% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $207.98 million.
Also, the Mutual Funds coming in first place with the largest holdings of Iovance Biotherapeutics Inc (IOVA) shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF . Data provided on Dec 31, 2024 indicates that VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund owns about 8.61 shares. This amounts to just over 2.58 percent of the company’s overall shares, with a $27.29 million market value. The same data shows that the other fund manager holds slightly less at 7.28, or about 2.18% of the stock, which is worth about $23.08 million.
